Beta Bionics (BBNX) financial statements
Beta Bionics reported revenue of $100M in fiscal 2025, up 189.1% a year over 2 years.
Net income was -$73M and the operating margin -71.5%, against -298.9% in 2023.
Free cash flow was -$56M.
The diluted share count rose 664% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Beta Bionics's 10-K filings with the SEC.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $12M | $65M | $100M |
| Cost of revenue | $6M | $29M | $45M |
| Gross profit | $6M | $36M | $56M |
| Research and development | $18M | $26M | $35M |
| Selling, general and admin | $24M | $55M | $92M |
| Operating income | -$36M | -$45M | -$72M |
| Income tax | — | $0 | $0 |
| Net income | -$44M | -$55M | -$73M |
| EPS (diluted) | -$8.31 | -$8.60 | -$1.81 |
| Diluted shares | 5M | 6M | 41M |
| Gross margin | 52.6% | 55.1% | 55.4% |
| Operating margin | -298.9% | -69.5% | -71.5% |
| Net margin | -367.6% | -84.1% | -73.0% |
Balance sheet
Fiscal years, from Beta Bionics's 10-K filings with the SEC.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Cash and short-term investments | $97M | $104M | $219M |
| Receivables | $4M | $12M | $17M |
| Inventory | $1M | $13M | $22M |
| Total current assets | $104M | $133M | $268M |
| Property, plant and equipment | $2M | $5M | $9M |
| Total assets | $110M | $150M | $329M |
| Total current liabilities | $11M | $21M | $31M |
| Total liabilities | $51M | $74M | $41M |
| Shareholders' equity | -$203M | -$245M | $288M |
| Net debt | -$27M | -$30M | -$32M |
Cash flow
Fiscal years, from Beta Bionics's 10-K filings with the SEC.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | -$32M | -$48M | -$51M |
| Capital spending | $402,000 | $3M | $5M |
| Free cash flow | -$33M | -$52M | -$56M |
| Stock-based compensation | $6M | $6M | $16M |
| Free cash flow margin | -273.8% | -79.3% | -56.1% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BBNX.
Open BBNX in InvestinglyQuestions
What was Beta Bionics's revenue in 2025?
$100M in fiscal 2025, from its 10-K filing.
How much free cash flow does Beta Bionics generate?
-$56M in fiscal 2025 (operating cash flow minus capital spending).
From Beta Bionics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.